23.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
What’s next for Amphastar Pharmaceuticals Inc. stock priceWeekly Gains Summary & Weekly Sector Rotation Insights - newser.com
Behavioral Patterns of AMPH and Institutional Flows - news.stocktradersdaily.com
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competition2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueOptions Play & Scalable Portfolio Growth Ideas - newser.com
Why Amphastar Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Market Activity Report & Low Risk Profit Maximizing Plans - newser.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Boston Trust Walden Corp Lowers Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock gain from lower interest ratesJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Using economic indicators to assess Amphastar Pharmaceuticals Inc. potentialAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Does Amphastar Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage? - Sahm
A Fresh Valuation Look at Amphastar Pharmaceuticals (AMPH) After US-China Trade Tensions Shake Healthcare Stocks - Sahm
What drives Amphastar Pharmaceuticals Inc 29A stock priceTrading Volume Trends & Free Short-Term Trading Strategies - earlytimes.in
Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know - TradingView
BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32 - MarketScreener
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Can Amphastar Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
How to monitor Amphastar Pharmaceuticals Inc. with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover after recent dropMarket Volume Summary & Expert Curated Trade Setups - newser.com
Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock return to pre crash levels2025 Volume Leaders & Growth Focused Entry Reports - newser.com
What analysts say about Cochlear Limited OC5 stockIPO Market Watch & Zero-Cost Stock Research by Professionals - earlytimes.in
Momentum divergence signals in Amphastar Pharmaceuticals Inc. chartAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - 富途牛牛
Is Amphastar Pharmaceuticals Inc. (29A) stock cheap vs fundamentalsEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares - MarketBeat
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside - DirectorsTalk Interviews
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):